Digoxin Lawsuit News and Information
Digoxin and Digitek Recall Lawsuits
Digitek brand and generic Digoxin tablets have been recalled due to some pills to contain too much or too little of the active ingredient than is appropriate. This could result in digoxin toxicity, which is a serious and potentially life-threatening injury.
All Articles Tagged With: "Digoxin"
Digitek Trial in Federal MDL Scheduled to Begin January 2011
A federal judge presiding over the consolidated Digitek litigation, which is centralized in the U.S. District Court for the Southern District of West Virginia, has scheduled the first trial over the recalled heart drug to being in January 2011.
Federal and State Judges to Hold Joint Hearing in Digitek Recall Lawsuits
The judges presiding over hundreds of Digitek recall lawsuits in federal court and various states will hold a joint hearing next year to review the scientific evidence in the cases, which involve allegations that extra-strength pills caused users throughout the United States to suffer severe and sometimes fatal heart problems in 2008.
Digitek Lawsuits Selected for First Trials in Federal MDL
Five Digitek overdose lawsuits have been selected to serve as “bellwether” cases that will lead the way for hundreds of cases filed against Actavis Totowa and distributors of their generic heart drug over deaths and other injuries allegedly caused by oversized pills that were recalled in April 2008.
Generic Adderall Recall: Oversized Barr Dextroamphetamine/Amphetamine
The FDA and Barr Laboratories, Inc. have announced a recall for generic Adderall tablets that may contain more of the active pharmaceutical ingredients than they are supposed to have, posing a risk of serious side effects among users of the ADHD drug.
Phenobarbital Recall in Canada Due to Oversized Tablets
Health Canada has issued a pms-Phenobarbital recall for 60 milligram tablets of the anxiety and seizure drug distributed by Pharmascience Inc., due to the possibility of that some tablets may be oversized. Receiving too much of the active medication could cause serious physical injury from overdose, such as coma or cardiac arrest.
Recalled Digoxin Manufacturer Raided by US Marshalls and FDA
At the request of the FDA, U.S. Marshals raided generic drug manufacturer Caraco Pharmaceutical Laboratories, Ltd., shutting down manufacturing and seizing inventory. The action came after FDA inspections found that the drug maker was continuing to fail to meet federal safety and health requirements.
Actavis Digitek Recall Has Resulted in 130 Lawsuits Consolidated in MDL
An additional 23 Digitek lawsuits filed against Actavis Totowa and their distributors in various federal district courts throughout the United States, have been transferred to the U.S. District Court for the Western District of Virginia, where they will be consolidated with at least 107 other cases that are being coordinated during pretrial proceedings as part [...]
Digoxin Drug Recall Issued by AS Medications Solutions
On May 11, 2009, the FDA posted notice of a digoxin drug recall issued by A S Medication Solutions, LLC, a drug repackaging company who distributed .25mg tablets manufactured by Caraco Pharmaceutical Laboratories, Ltd. The tablets could contain too much or too little of the drug, potentially increasing the risk of digoxin toxicity. [...]
Digitek Lawsuit Filed on Behalf of 97 Plaintiffs in Illinois
An Illinois lawsuit has been filed in St. Clair County Circuit Court on behalf of 97 people who allege injuries and damages caused by recalled Digitek tablets that were allegedly manufactured with more of the prescribed heart drug than they were supposed to contain.
Digoxin Recall Causes Other Generic Drug Makers to Step Up Supply
Following the nationwide recall of Digoxin manufactured by Caraco Pharmaceutical Laboratories, which was issued due to potentially oversized and undersized tablets, other generic drug makers have indicated that they are prepared to supply the U.S. market with safe tablets for heart patients.
Contact a Lawyer
Submit information about your potential case to be reviewed by an attorney.
